LIST OF TABLES
TABLE 1 AGEING WORLD POPULATION
TABLE 2 POSTOPERATIVE PULMONARY EMBOLISM OR DEEP VEIN THROMBOSIS IN HIP AND KNEE SURGERIES, 2015
TABLE 3 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA DEEP VEIN THROMBOSIS (DVT) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA PULMONARY EMBOLISM (PE) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA ARTERIAL THROMBOEMBOLISM (AT) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA STROKE IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA OTHERS IN MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA NOVEL ORAL ANTICOAGUALTANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA BIVALIRUDIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA DABIGATRAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA EDOXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA BETRIXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA RIVAROXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA APIXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA ENOXAPARIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA DALTEPARIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION , 2017-2026 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA ORAL IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA INJECTABLES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA INJECTABLES IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA ONCOLOGY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA RESPIRATORY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA NEPHROLOGY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA CNS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA PRE-SURGICAL PROCEDURES IN MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA POST-SURGICAL PROCEDURES IN MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA KIDNEY DIALYSIS IN MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA HEART VALVE REPLACEMENT IN MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA GENERICS IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA BRANDED IN MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA HOSPITALS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA CLINICS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA HOMECARE IN ANTICOAGULATION THERAPY MARKET,BY REGION, 2017-2026 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA HOSPITAL PHARMACY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 56 RETAIL PHARMACIES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 57 MIDDLE EAST AND AFRICA ONLINE PHARMACIES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 58 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 59 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 60 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 61 MIDDLE EAST AND AFRICA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 62 MIDDLE EAST AND AFRICA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 63 MIDDLE EAST AND AFRICA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 64 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 65 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 66 MIDDLE EAST AND AFRICA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 67 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 68 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 69 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 70 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 71 MIDDLE EAST AND AFRICA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 72 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 73 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 74 U.S. ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 75 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 76 SOUTH AFRICA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 77 SOUTH AFRICA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 78 SOUTH AFRICA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 79 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 80 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 81 SOUTH AFRICA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 82 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 83 SOUTH AFRICA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 84 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 85 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 86 SOUTH AFRICA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 87 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 88 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 89 REST OF MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
LIST OF FIGURE
LIST OF FIGURES
FIGURE 1 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET
FIGURE 2 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: DATA VALIDATION MODEL
FIGURE 3 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: MIDDLE EAST AND AFRICA VS REGIONAL ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 9 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET
FIGURE 10 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE OF VENOUS THROMBOEMBOLISM AND PULMONARY EMBOLISM AND GROWING NUMBER OF SURGERIES ARE EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 12 DEEP VEIN THROMBOSIS(DVT) IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET IN 2019 & 2026
FIGURE 13 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: BY TREATMENT, 2018
FIGURE 14 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: BY THERAPEUTIC CLASS, 2018
FIGURE 15 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: BY DRUG TYPE, 2018
FIGURE 16 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: BY ROUTE OF ADMINISTRATION, 2018
FIGURE 17 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: BY THERAPEUTIC AREA, 2018
FIGURE 18 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY TREATMENT MARKET: BY PROCEDURE, 2018
FIGURE 19 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: BY TYPE, 2018
FIGURE 20 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: BY END USER, 2018
FIGURE 21 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: BY DISTRIBUTION CHANNEL, 2018
FIGURE 22 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: SNAPSHOT (2018)
FIGURE 23 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: BY COUNTRY (2018)
FIGURE 24 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: BY COUNTRY (2019)
FIGURE 25 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: BY COUNTRY (2018 & 2026)
FIGURE 26 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET: BY TREATMENT (2019-2026)
FIGURE 27 MIDDLE EAST AND AFRICA ANTICOAGULATION THERPAY MARKET: COMPANY SHARE 2018 (%)
